|Nombre:||Competition and Antitrust Issues in the Pharmaceutical Industry|
This paper describes antitrust issues related to the pharmaceutical industry, focusing on the production and distribution of prescription drugs, including originator and generic products. OTC products are included to a much lesser extent. It also describes the major economic characteristics of the pharmaceutical industry that intersect with antitrust policy, including patent and regulatory policies, and the roles of insurers, physicians and retail pharmacies that act as agents for patients/customers. It briefly examines antitrust issues in countries with less mature regulatory systems and with predominantly self-pay markets for outpatient drugs, an draws conclusions.
|Nombre:||Competition and Antitrust Issues in the Pharmaceutical IndustryFinal7 2 14.pdf|
|Tipo:||pdf (Mime Type: application/pdf)|
|Createdo el:||09/17/2014 00:00|
|Última actualización el:||10/03/2014 12:26|
|Página de inicio:|